UPDATED: Ex-Genentech dream team garners $217M to launch neurodegenerative player Denali

A group of high-profile ex-Genentech execs has rounded up a monster $217 million A round to launch Denali Therapeutics with plans to tackle neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease and ALS.

Source: www.fiercebiotech.com

---